Urology Times Innovation Celebration Video Series : Episode 13
Video
Urology Times 50 Innovations Series: Treatment of female hypoactive sexual desire disorder
Author(s):
"We as urologists are board certified to take care of all genders. We are really good sexual medicine doctors, and we need to apply what we know about sexual medicine, not just for our male patients, but for all of our patients," says Rachel S. Rubin, MD
Video Player is loading.
As part of the Urology Times' 50th Anniversary Innovation Celebration, Rachel S. Rubin, MD, discusses the evolution in the treatment of female hypoactive sexual desire disorder. Rubin is a board-certified urologist with fellowship training in sexual medicine. She is an assistant clinical professor in urology at Georgetown University and recently started a private practice in the Washington DC area.
Related Videos
FDA testosterone labeling changes: How will they affect prescribing?
Landon Trost, MD, on the impact of the FDA labeling changes for testosterone products
How urologists can discuss testosterone labeling changes with patients
John P. Mulhall, MD, shares his reaction to the FDA’s testosterone labeling changes
An expert shares their approach to testosterone therapy in men with hypogonadism
Helen L. Bernie, DO, MPH, on the FDA’s labeling changes for testosterone products
Dayna R. Smerina and Amy M. Pearlman, MD, discuss their research in sexual medicine
Top 10 Urology Times videos of 2024
Does varicocele affect prostate cancer outcomes?
Study points to increased public interest in vaginal estrogen
Related Content
